Sequent scientific / Viyash Scientific Ltd
Viyash Scientific Ltd operates across formulations, APIs and CDMO services, with growth focused on complex products, animal health, emerging markets and higher-value pharmaceutical opportunities.
Reports:
- Viyash Scientific Limited l BUY l TP: INR 345 Formulations drive robust growth Aug 2026
- Viyash Scientific Limited l BUY l TP: INR 330 Investor Day: Top notch management; compounding business June 2026
- Viyash Scientific Limited l BUY l TP: INR 355 Sustains high margins, focus on new growth avenues May 2026
- SeQuent Scientific Limited l BUY l TP: INR 275 Pivoting to profitability May 2025
- SeQuent Scientific Limited l BUY l TP: INR 295 Synergies in motion August 2025
- SeQuent Scientific Limited l BUY l TP: INR 275 Strong recovery visible February 2025
- SeQuent Scientific Limited - Initiating coverage January 2025

